Brought to you by 
On-Q-ity brings in $21mm through its Series A round
30 Nov 2009
Executive Summary
Cancer diagnostics company On-Q-ity has raised $21mm through its Series A round, which was led by Mohr Davidow Ventures and included investments from Bessemer Venture Partners, Physic Ventures, and Northgate Capital. Mohr, Bessemer, and Physic all take seats on the company's board.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
On-Q-ity brings in $21mm through its Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice